{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:07:53Z","timestamp":1723939673483},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Inherited metabolic diseases (IMDs) stem from genetic defects affecting enzyme function within specific metabolic pathways, collectively constituting rare conditions with an incidence of less than 1\/100,000 births. While IMDs typically manifest with multisystemic symptoms, cardiac manifestations are common, notably hypertrophic cardiomyopathy. Additionally, they can lead to dilated or restrictive cardiomyopathy, as well as noncompacted left ventricular cardiomyopathy. Rhythm disturbances such as atrioventricular conduction abnormalities, Wolff-Parkinson-White syndrome, and ventricular arrhythmias, along with valvular pathologies and ischemic coronary issues, are also prevalent. This study aims to provide a narrative review of IMDs associated with cardiac involvement, delineating the specific cardiac manifestations of each disorder alongside systemic symptoms pivotal for diagnosis.<\/jats:p>","DOI":"10.1097\/crd.0000000000000753","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:06:56Z","timestamp":1720530416000},"update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Manifestations in Inherited Metabolic Diseases"],"prefix":"10.1097","author":[{"given":"Mubeena","family":"Javed","sequence":"first","affiliation":[{"name":"Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danish Kumar","family":"Goswami","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hem","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Lohana","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barkha","family":"Goswami","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Karim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allah","family":"Warayo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palwasha","family":"Farooqi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kabul University of Medical Sciences, Kabul, Afghanistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon","family":"Alamy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kabul University of Medical Sciences, Kabul, Afghanistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab Obaid","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Fatima Jinnah Medical University, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamer","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rajiv Gandhi University of Health Sciences, Bengaluru, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Ahmad","family":"Farooqi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsah","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darab","family":"Shuja","sequence":"additional","affiliation":[{"name":"Department of Medicine, Services Hospital, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jahanzeb","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cardiovascular Analytics Group, Islamabad, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulfiqar Qutrio","family":"Baloch","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Ascension Borgess Hospital, Michigan, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"R2-20240817","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","article-title":"Incidence of inborn errors of metabolism in British Columbia, 1969-1996.","volume":"105","author":"Applegarth","year":"2000","journal-title":"Pediatrics"},{"key":"R3-20240817","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/adc.2005.091637","article-title":"The incidence of inherited metabolic disorders in the West Midlands, UK.","volume":"91","author":"Sanderson","year":"2006","journal-title":"Arch Dis Child"},{"key":"R4-20240817","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders.","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"R5-20240817","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands.","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Genet"},{"key":"R6-20240817","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening.","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R7-20240817","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pcad.2009.11.002","article-title":"Anderson-Fabry disease and the heart.","volume":"52","author":"O\u2019Mahony","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"R8-20240817","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2008.03.007","article-title":"Onset and progression of the Anderson-Fabry disease related cardiomyopathy.","volume":"130","author":"Kampmann","year":"2008","journal-title":"Int J Cardiol"},{"key":"R9-20240817","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp588","article-title":"Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alphagalactosidase A activity.","volume":"31","author":"Wu","year":"2010","journal-title":"Eur Heart J"},{"key":"R10-20240817","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease.","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R12-20240817","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.medcli.2016.09.047","article-title":"Diagnosis and treatment of Fabry disease.","volume":"148","author":"Ortiz","year":"2017","journal-title":"Med Clin"},{"key":"R13-20240817","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document.","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R14-20240817","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejim.2013.09.006","article-title":"Gaucher disease: a diagnostic challenge for internists.","volume":"25","author":"Cassinerio","year":"2014","journal-title":"Eur J Intern Med"},{"key":"R15-20240817","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/aam.aam_64_18","article-title":"Restrictive cardiomyopathy: a rare presentation of gaucher disease.","volume":"20","author":"Kundu","year":"2021","journal-title":"Ann Afr Med"},{"key":"R16-20240817","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(95)91688-1","article-title":"Gaucher\u2019s disease variant characterised by progressive calcification of heart valves and unique genotype.","volume":"346","author":"Abrahamov","year":"1995","journal-title":"Lancet"},{"key":"R17-20240817","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/ATVBAHA.113.302426","article-title":"Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia.","volume":"33","author":"Stitziel","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R18-20240817","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency\u2013an under-recognized cause of dyslipidaemia and liver dysfunction.","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis"},{"key":"R19-20240817","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.","volume":"58","author":"Bernstein","year":"2013","journal-title":"J Hepatol"},{"key":"R20-20240817","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2019.11.004","article-title":"Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: consensus recommendations from an international collaborative working group.","volume":"129","author":"Kohli","year":"2020","journal-title":"Mol Genet Metab"},{"key":"R21-20240817","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11926-013-0389-0","article-title":"Mucopolysaccharidoses.","volume":"16","author":"Cimaz","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"R22-20240817","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejim.2016.05.017","article-title":"Unique medical issues in adult patients with mucopolysaccharidoses.","volume":"34","author":"Mitchell","year":"2016","journal-title":"Eur J Intern Med"},{"key":"R23-20240817","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/diagnostics11020273","article-title":"Epidemiology of mucopolysaccharidoses update.","volume":"11","author":"Celik","year":"2021","journal-title":"Diagnostics"},{"key":"R24-20240817","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/heartjnl-2015-309258","article-title":"Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs.","volume":"102","author":"Braunlin","year":"2016","journal-title":"Heart"},{"key":"R25-20240817","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9149(76)90468-9","article-title":"The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases.","volume":"38","author":"Renteria","year":"1976","journal-title":"Am J Cardiol"},{"key":"R26-20240817","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.","volume":"34","author":"Braunlin","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"R27-20240817","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.carpath.2014.01.001","article-title":"Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review.","volume":"23","author":"Braunlin","year":"2014","journal-title":"Cardiovasc Pathol"},{"key":"R30-20240817","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","article-title":"Glycogen storage diseases: new perspectives.","volume":"13","author":"Ozen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R31-20240817","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.3390\/ijms22094381","article-title":"Biomarkers in glycogen storage diseases: an update.","volume":"22","author":"Molares-Vila","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R32-20240817","first-page":"99","article-title":"Cardiac phenotype in glycogen storage disease type XV: a rare cardiomyopathy to bear in mind.","volume":"74","author":"Mancheno","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R33-20240817","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00001573-200205000-00004","article-title":"PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.","volume":"17","author":"Gollob","year":"2002","journal-title":"Curr Opin Cardiol"},{"key":"R34-20240817","first-page":"42","article-title":"El auge de las enfermedades mitocondriales.","volume":"33","author":"Gort","year":"2018","journal-title":"Ed Cont Lab Clin"},{"key":"R37-20240817","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.cjca.2015.08.017","article-title":"Mitochondrial diseases and cardiomyopathies.","volume":"31","author":"Brunel-Guitton","year":"2015","journal-title":"Can J Cardiol"},{"key":"R38-20240817","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biology8020034","article-title":"Cardiovascular manifestations of mitochondrial disease.","volume":"8","author":"Duran","year":"2019","journal-title":"Biology"},{"key":"R39-20240817","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10545-017-0135-2","article-title":"Organic acidurias in adults: late complications and management.","volume":"41","author":"Tuncel","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"R40-20240817","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10238-016-0435-0","article-title":"\u201cClassical organic acidurias\u201d: diagnosis and pathogenesis.","volume":"17","author":"Villani","year":"2017","journal-title":"Clin Exp Med"},{"key":"R41-20240817","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ped.13272","article-title":"Cardiac manifestations of inherited metabolic disease in children.","volume":"59","author":"Lloyd","year":"2017","journal-title":"Pediatr Int"},{"key":"R42-20240817","doi-asserted-by":"crossref","first-page":"617451","DOI":"10.3389\/fcvm.2020.617451","article-title":"Cardiac complications of propionic and other inherited organic acidemias.","volume":"7","author":"Park","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"R43-20240817","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10545-013-9600-8","article-title":"Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation.","volume":"36","author":"Kolker","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"R44-20240817","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41436-020-01070-0","article-title":"Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders.","volume":"23","author":"Marsden","year":"2021","journal-title":"Genet Med"},{"key":"R46-20240817","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1024445402983","article-title":"Overview of inherited metabolic disorders causing cardiovascular disease.","volume":"26","author":"Wilcken","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"R47-20240817","doi-asserted-by":"crossref","first-page":"473","DOI":"10.21037\/atm.2018.10.57","article-title":"Fatty acid oxidation disorders.","volume":"6","author":"Merritt","year":"2018","journal-title":"Ann Transl Med"},{"key":"R48-20240817","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11154-020-09568-3","article-title":"Clinical manifestations and management of fatty acid oxidation disorders.","volume":"21","author":"Merritt","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"R49-20240817","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2013.04.009","article-title":"Clinical and biochemical aspects of primary and secondary hyperammonemic disorders.","volume":"536","author":"Haberle","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"R50-20240817","doi-asserted-by":"crossref","first-page":"313","DOI":"10.12997\/jla.2020.9.3.313","article-title":"Mitochondrial fatty acid oxidation disorders: laboratory diagnosis, pathogenesis, and the complicated route to treatment.","volume":"9","author":"Wanders","year":"2020","journal-title":"J Lipid Atheroscler"},{"key":"R51-20240817","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/17474124.2013.816114","article-title":"Diagnosis and treatment of hereditary hemochromatosis: an update.","volume":"7","author":"Kanwar","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R52-20240817","first-page":"183","article-title":"Hereditary hemochromatosis.","volume":"87","author":"Crownover","year":"2013","journal-title":"Am Fam Physician"},{"key":"R53-20240817","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMra2119758","article-title":"Hemochromatosis.","volume":"387","author":"Olynyk","year":"2022","journal-title":"N Engl J Med"},{"key":"R54-20240817","first-page":"e20009","article-title":"Hereditary hemochromatosis: a cardiac perspective.","volume":"13","author":"Joshi","year":"2021","journal-title":"Cureus"},{"key":"R55-20240817","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG clinical guideline: hereditary hemochromatosis.","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R56-20240817","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5582\/irdr.2017.01057","article-title":"Epidemiology, diagnosis, and treatment of Wilson\u2019s disease.","volume":"6","author":"Liu","year":"2017","journal-title":"Intractable Rare Dis Res"},{"key":"R57-20240817","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jimd.12418","article-title":"Cardiac involvement in Wilson disease: Review of the literature and description of three cases of sudden death.","volume":"44","author":"Chevalier","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"R58-20240817","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.medcli.2022.12.016","article-title":"Wilson\u2019s disease: overview.","volume":"160","author":"Lucena-Valera","year":"2023","journal-title":"Med Clin"},{"key":"R59-20240817","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","article-title":"Diagnosis and phenotypic classification of Wilson disease.","volume":"23","author":"Ferenci","year":"2003","journal-title":"Liver Int"},{"key":"R60-20240817","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2017.101","article-title":"Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.","volume":"19","author":"Chinsky","year":"2017","journal-title":"Genet Med"},{"key":"R61-20240817","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13023-017-0599-z","article-title":"Newborn screening for Tyrosinemia type 1 using succinylacetone - a systematic review of test accuracy.","volume":"12","author":"Stinton","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"R62-20240817","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10545-006-0203-5","article-title":"Cardiomyopathy in tyrosinaemia type I is common but usually benign.","volume":"29","author":"Arora","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"R63-20240817","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1756-0500-6-362","article-title":"Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy.","volume":"6","author":"Mohamed","year":"2013","journal-title":"BMC Res Notes"},{"key":"R64-20240817","doi-asserted-by":"crossref","first-page":"279.e1","DOI":"10.1016\/j.anpedi.2010.03.005","article-title":"Recommendations and management of type I hereditary or hepatorenal tyrosinemia.","volume":"73","author":"Couce","year":"2010","journal-title":"An Pediatr"},{"key":"R65-20240817","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jcp-2021-208029","article-title":"Homocystinuria diagnosis and management: it is not all classical.","volume":"75","author":"Gerrard","year":"2022","journal-title":"J Clin Pathol"},{"key":"R66-20240817","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R67-20240817","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.","volume":"83","author":"Humphrey","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R68-20240817","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","article-title":"Biochemical functions of coenzyme Q10.","volume":"20","author":"Crane","year":"2001","journal-title":"J Am Coll Nutr"},{"key":"R69-20240817","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/antiox12081652","article-title":"Primary coenzyme Q10 deficiency: an update.","volume":"12","author":"Mantle","year":"2023","journal-title":"Antioxidants"},{"key":"R70-20240817","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10545-014-9749-9","article-title":"Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.","volume":"38","author":"Desbats","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"R71-20240817","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/cge.14182","article-title":"Expanding the clinical spectrum of primary coenzyme Q10 deficiency type 6: the first case with cardiomyopathy.","volume":"102","author":"Leeuwen","year":"2022","journal-title":"Clin Genet"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T17:01:43Z","timestamp":1723914103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":64,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000753","relation":{},"ISSN":["1061-5377"],"issn-type":[{"type":"print","value":"1061-5377"}],"subject":[],"published":{"date-parts":[[2024,7,9]]}}}